Latest News & Updates

Breaking News

  • 2 hours ago

  • Simantini Singh Deo

Alkem Launches DCGI-Approved Semaglutide Pre-Filled Syringes in India at Rs. 350 Per Dose
Breaking News
Cipla Appoints Taher Karampurwala as Senior Director to Head Middle East Business

Simantini Singh Deo

Other trending news you may like to read

Alkem Launches DCGI-Approved Semaglutide Pre-Filled Syringes in India at Rs. 350 Per Dose

Alkem launches DCGI-approved semaglutide pre-filled syringes at Rs. 350, raising fill-finish, cold-chain, and regulatory compliance questions for Indian GLP-1 manufacturers.

Simantini Singh Deo

Pharma Now

Cipla Appoints Taher Karampurwala as Senior Director to Head Middle East Business

Cipla relocates a senior executive to Saudi Arabia to lead Middle East operations, signalling deeper regulatory and commercial commitment across Gulf markets.

Simantini Singh Deo

Pharma Now

AB Science Advances Masitinib ALS Phase 3 Trial as AB8939 Emerges as Second Pipeline Pillar

AB Science's FDA-authorized ALS Phase 3 trial and AML programme advance as Stonegate assigns €4.25/share DCF valuation.

Simantini Singh Deo

Pharma Now

Sapience Therapeutics Achieves Phase 2 Milestone for Lucicebtide in Newly Diagnosed Glioblastoma

Sapience Therapeutics releases Phase 2 data for lucicebtide plus chemoradiation in newly diagnosed GBM, covering efficacy, pharmacodynamics, and safety.

Vaibhavi M.

Pharma Now